Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Edelweiss Securities is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2530 in its research report dated December 02, 2021.

Buy Ipca Laboratories; Target Of Rs 2530: Edelweiss Securities

Near-term growth potential seems to be moderate for Ipca Laboratories but the long-term growth levers are intact and the acquisition of Lyka Labs will likely open strong opportunities

Lyka Labs Acquisition By Ipca Laboratories Could Open Strong Growth Opportunities

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 2675 in its research report dated November 24, 2021.

Buy Ipca Laboratories: Target Of Rs 2675: Sharekhan

In total, Ipca Labs, so far, bought 76,24,142 equity shares or 26.57 percent stake in Lyka Labs via open market transactions in the current week. Lyka Labs was locked in 5 percent upper circuit today at Rs 135.

Bulk Deals | Ipca Labs Picks 16.73% Stake In Lyka Labs, Dolly Khanna Buys 0.58% Shares In Simran Farms

Makes its entry into lyophilized injectables biz

Ipca Laboratories to pick up 26.57% stake in Lyka for ₹97.89 cr

Makes its entry into the lyophilized injectables business.

Ipca to pick up 26.57 per cent stake in Lyka for ₹97.89 crore

Lyka Labs is engaged in the manufacturing and marketing of injectables, lyophilized injectables and topical formulations

Ipca Labs’ board approves acquisition of over 26% stake in Lyka Labs

IPCA Laboratories said that its board of directors has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs for a cash consideration of Rs 97.89 crore.

IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer

IPCA Laboratories has agreed to acquire more than 26% stake in Lyka Labs, triggering an open offer.

IPCA Labs To Buy More Than 26% Stake In Lyka Labs; Shares Jump

Board of Ipca Laboratories approves acquisition of 26.57% in Lyka Labs

Buzzing stocks: Siemens, IPCA Lab, Lyka Labs, Bharti Airtel, Zee Entertainment, Patel Integrated, Poonawalla Fincorp, Affordable Robotic, HFCL

Stocks that will see action on November 24

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).

IPCA Laboratories Ltd

IPCA Laboratories Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Ipca Laboratories; Target Of Rs 2530: Edelweiss Securities

Lyka Labs Acquisition By Ipca Laboratories Could Open Strong Growth Opportunities

Buy Ipca Laboratories: Target Of Rs 2675: Sharekhan

Bulk Deals | Ipca Labs Picks 16.73% Stake In Lyka Labs, Dolly Khanna Buys 0.58% Shares In Simran Farms

Ipca Laboratories to pick up 26.57% stake in Lyka for ₹97.89 cr

Ipca to pick up 26.57 per cent stake in Lyka for ₹97.89 crore

Ipca Labs’ board approves acquisition of over 26% stake in Lyka Labs

IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer

IPCA Laboratories Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Ipca Laboratories; Target Of Rs 2530: Edelweiss Securities

Lyka Labs Acquisition By Ipca Laboratories Could Open Strong Growth Opportunities

Buy Ipca Laboratories: Target Of Rs 2675: Sharekhan

Bulk Deals | Ipca Labs Picks 16.73% Stake In Lyka Labs, Dolly Khanna Buys 0.58% Shares In Simran Farms

Ipca Laboratories to pick up 26.57% stake in Lyka for ₹97.89 cr

Ipca to pick up 26.57 per cent stake in Lyka for ₹97.89 crore

Ipca Labs’ board approves acquisition of over 26% stake in Lyka Labs

IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock